Product Pipeline

TriFlect™ technology expands protection across a number of different products and new treatments.

Eye Care and Therapeutics

Learn More
LEAD INDICATION
Contact lens disinfection solution
STATUS
Clinical / Commercial
MAJOR MILESTONES
Human clinical trial established safety for disinfection of contact lenses for use in eye

1-Hour disinfection claim; FDA clearance expected May 2019

Beats all existing commercial products in potency of disinfection

Commercial launch of lead product in 2019

Topical Anti-Virals

Learn More
LEAD INDICATION
Topical treatment for herpes skin infections / cold sores
STATUS
Pre-Clinical
MAJOR MILESTONES
INDA filing with FDA in late 2019 / early 2020

Rapid advancement through clinical trials (Phase I clinical studies done by 2H2020)

Topical Anti-Fungals

Learn More
LEAD INDICATION
Treatment for Onychomycosis / Toe Nail Fungus
PHASE
Discovery / Pre-Clinical
MAJOR MILESTONES
Stronger efficacy beats leading anti-fungal products

Further R&D underway

Wound & Burn Care

Learn More
LEAD INDICATION
Topical disinfecting / bioprotectant ointment for severe burns
PHASE
Discovery
MAJOR MILESTONES
Animal models show increased speed of healing and reduced scarring

Further R&D underway

Surgical Disinfection

Learn More
LEAD INDICATION
Coated hernia meshes, catheters, and implanted ortho devices
PHASE
Discovery
MAJOR MILESTONES
In discussions with medical device companies evaluating technology for use with implants

Development Phases:

DISCOVERY
PRE-CLINICAL
CLINICAL
COMMERCIAL
Additional opportunities available for licensing and development. Contact us.